PW06 - TB Workshop

Wednesday, October 11, 2023

8:00 AM – 12:00 PM US ET

Location: 258 ABC

All relevant financial disclosures have been mitigated.

Workshop Moderator(s)

Yukari Manabe, MD, FIDSA, FRCP

Professor
Johns Hopkins University School of Medicine
Baltimore, MD, United States

Slides
Maunank Shah, MD, PhD

Associate Professor
Johns Hopkins
Baltimore, MD, United States

Slides

Faculty(s)

Emily Erbelding, MD

Director, Division of Microbiology and Infectious Disease NIAID
National Institutes of Health
Rockville, MD, United States

Slides
Janie Louie, Doctor of Medicine, Master of Public Health (she/her/hers)

Medical Director
San Francisco Department of Public Health
Oakland, CA, United States
Connie Haley, MD MPH

Medical Consultant
Southeastern National TB Center
University of Florida
Nashville, TN, United States

Slides
Angela Starks, PhD (she/her/hers)

Branch Chief
CDC Division of TB Elimination/ Laboratory Branch
Atlanta, GA, United States

Slides
Ruvandhi Nathavitharana, MD, MPH

Assistant Professor
Beth Israel Deaconess Medical Center
Boston, MA, United States
Nicole Salazar-Austin, MD, ScM (she/her/hers)

Assistant Professor
Johns Hopkins
Baltimore, MD, United States
Marcos Schechter, MD

Associate Professor
Emory University School of Medicine
Atlanta, GA, United States
Caitlin Reed, MD, MPH

Medical Team Lead, Division of TB Elimination
Centers for Disease Control and Prevention
Atlanta, GA, United States

Disclosure(s):

Yukari C. Manabe, MD, FIDSA, FRCP: Cepheid, Inc: Grant/Research Support (Ongoing); ChemBio: Grant/Research Support (Ongoing); Hologic Inc: Grant/Research Support (Ongoing); Roche Diagnostics: Grant/Research Support (Ongoing)

Maunank Shah, MD, PhD: Scene Health: IP licensed to Scene, for video-DOT (Ongoing)

CME Credits: Maximum of 4 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 4 hours of MOC Credit
CNE Credits: Maximum of 4 hours of ANCC Credit
ACPE Credits: ACPE 4 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-23-002-L01-P

Co-organized by the National TB Controller's Association

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe the latest updates in research and development of new TB products;
describe the latest diagnostic tools for TB;
describe the latest treatment options for TB;
apply the latest evidence-based strategies for management of TB infection.

Presentations:

8:00 AM – 8:20 AM US ET

Introduction: The State of TB
Workshop Speaker: Yukari C. Manabe, MD, FIDSA, FRCP – Johns Hopkins University School of Medicine
8:20 AM – 8:50 AM US ET

Research Priorities in Tuberculosis
Workshop Speaker: Emily Erbelding, MD – National Institutes of Health
8:50 AM – 9:10 AM US ET

Real-World Application of Short-Course Treatment Regimens
Workshop Speaker: Janie Louie, Doctor of Medicine, Master of Public Health (she/her/hers) – San Francisco Department of Public Health
9:10 AM – 9:30 AM US ET

From Policy to Practice: Real-World Implementation of BPaL Regimen for M/XDR TB Treatment
Workshop Speaker: Connie A. Haley, MD MPH – University of Florida
9:30 AM – 10:00 AM US ET

What’s New in M. Tuberculosis Drug Susceptibility Testing?
Workshop Speaker: Angela Starks, PhD (she/her/hers) – CDC Division of TB Elimination/ Laboratory Branch
10:30 AM – 12:00 PM US ET

Clinical Case Studies & Panel Discussion
Workshop Moderator: Maunank Shah, MD, PhD – Johns Hopkins
Workshop Speaker: Ruvandhi Nathavitharana, MD, MPH – Beth Israel Deaconess Medical Center
Workshop Speaker: Nicole Salazar-Austin, MD, ScM (she/her/hers) – Johns Hopkins
Workshop Speaker: Marcos Schechter, MD – Emory University School of Medicine
Workshop Speaker: Caitlin Reed, MD, MPH – Centers for Disease Control and Prevention